Ligand Pharmaceuticals
LGND
#4005
Rank
NZ$4.03 B
Marketcap
$196.02
Share price
-1.85%
Change (1 day)
56.85%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2024 (TTM): NZ$0.10 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.15 Billion. In 2023 the company made an earning of NZ$0.11 Billion a decrease over its 2022 earnings that were of NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.10 B-9.59%
2023 NZ$0.11 B-7.59%
2022 NZ$0.12 B4%
2021 NZ$0.11 B296.42%
2020 NZ$30.05 M-97.97%
2019 NZ$1.48 B275.62%
2018 NZ$0.39 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$78.43 M55.41%
2015 NZ$50.46 M36.87%
2014 NZ$36.87 M29.59%
2013 NZ$28.45 M1309.35%
2012 NZ$2.01 M-43.97%
2011 NZ$3.6 M-113.19%
2010 -NZ$27.32 Million59.86%
2009 -NZ$17.09 Million-61.33%
2008 -NZ$44.2 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$88.9 Million81.27%
2005 -NZ$49.04 Million
2003 -NZ$34.15 Million-20.6%
2002 -NZ$43 Million4.38%
2001 -NZ$41.2 Million-48.83%
2000 -NZ$80.5 Million-19.74%
1999 -NZ$0.11 Billion-19.06%
1998 -NZ$0.13 Billion126.71%
1997 -NZ$54.66 Million-5.83%
1996 -NZ$58.04 Million136.23%
1995 -NZ$24.57 Million-33.97%
1994 -NZ$37.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$8.20 B 7,443.87%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.12 Billion-201.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.42 B 6,726.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$26.65 B 24,407.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.36 B 11,264.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.57 B 20,654.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.92 Billion-13,814.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.29 B 171.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.05 B 28,448.51%๐Ÿ‡บ๐Ÿ‡ธ USA